BeStock  
Stocks › Biotechnology › CLDX

Celldex Therapeutics CLDX

US equityMarket cap rank #2636Biotechnology
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.7x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -12.4x

Price / book3.5x
CheapRich

Around its usual level · 45th percentile, 5-year average 4.0x

#3953 of 5330 stocks by PB (1 = cheapest)

Price / sales14,332.0x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average 1,656.3x

#5144 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-37x-26x-15x-4xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$52.65
Price vs. fair value-47.9%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.49 – 4.04 45% (cheaper than usual) #3953 of 5330 (1 = cheapest)
PE -6.72 -6.93 -12.36 99% (pricier than usual) –
PS 14,331.99 1,000.38 1,656.30 95% (pricier than usual) #5144 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CLDX.

Sign in to join the discussion.

Scroll to Top